Associated Papers
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
Kohsaka S et al.
Nature Genetics, 2014
Select a paper to view details
Kohsaka S et al.
Nature Genetics, 2014